cbdMD (YCBD) Other Non-Current Assets (2016 - 2025)

cbdMD (YCBD) reported Other Non-Current Assets of $62708.0 for Q4 2025, down 98.79% on a YoY basis from $5.2 million in Q4 2024, and little changed sequentially from $62708.0 in Q3 2025.

cbdMD (YCBD) Other Non-Current Assets (2016 - 2025) Analysis & Trends

cbdMD (YCBD) has 10 years of Other Non-Current Assets data on file, last reported at $62708.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets fell 98.79% year-over-year to $62708.0; the trailing twelve-month figure through Dec 2025 stood at $62708.0 (down 98.79% YoY), and the FY2025 full-year result was $62708.0, down 98.5% from the prior year.
  • Other Non-Current Assets steadied at $62708.0 in Q4 2025, from $62708.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $88.4 million in Q3 2021 to a low of $62708.0 in Q1 2025.
  • A 5-year average of $9.1 million and a median of $191657.0 in 2022 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets tumbled 99.8% in 2022 and jumped 4625.25% in 2024, its largest moves.
  • Tracing YCBD's Other Non-Current Assets over 5 years: stood at $69.6 million in 2021, then plunged by 99.8% to $138708.0 in 2022, then slipped by 4.69% to $132203.0 in 2023, then jumped by 3819.94% to $5.2 million in 2024, then slumped by 98.79% to $62708.0 in 2025.
  • Business Quant data shows YCBD's Other Non-Current Assets at $62708.0 in Q4 2025, $62708.0 in Q3 2025, and $4.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn 62,708.00

Historic Data

Download Data
DateValue
Dec 31, 2025 62,708.00
Sep 30, 2025 62,708.00
Jun 30, 2025 4.30 Mn
Mar 31, 2025 62,708.00
Dec 31, 2024 5.18 Mn
Sep 30, 2024 4.19 Mn
Jun 30, 2024 6.55 Mn
Mar 31, 2024 132,203.00
Dec 31, 2023 132,203.00
Sep 30, 2023 138,708.00
Jun 30, 2023 138,708.00
Mar 31, 2023 138,708.00
Dec 31, 2022 138,708.00
Sep 30, 2022 244,606.00
Jun 30, 2022 244,606.00
Mar 31, 2022 138,708.00
Dec 31, 2021 69.65 Mn
Sep 30, 2021 88.38 Mn
Jun 30, 2021 529,583.00
Mar 31, 2021 789,583.00